Platelet aggregation and recruitment with aspirin-clopidogrel therapy

Cerebrovascular Diseases

Volumn 25, Issue 5, 2008, Pages 392-400

  Helgason, Cathy M ^a   Grossi, Enzo ^b   Pandey, Dilip ^a   Valika, Aziz ^a   Cursio, John ^a   Brace, Larry D ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b Bracco SpA   (Italy)

Author keywords

Aspirin resistance; Aspirin clopidogrel; Nonlinear mapping; Platelet aggregation; Platelet reactivity; Platelet recruitment

Indexed keywords

11 OXOTHROMBOXANE B2; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; COLLAGEN;

ANALYSIS OF VARIANCE; ARTICLE; CELL ASSAY; CELL MIGRATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; MONOTHERAPY; NONLINEAR SYSTEM; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOCYTE KINETICS; URINARY EXCRETION;

ASPIRIN; BRAIN ISCHEMIA; COHORT STUDIES; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; STROKE; THROMBOXANE B2; TICLOPIDINE;

EID: 44449175645     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121339     Document Type: Article

References (27)

1. Helgason CM, Tortorice KL, Winkler SR, Penney DW, Schuler JJ, McClelland TJ, Brace LD: Aspirin response and failure in cerebral infarction. Stroke 1993;24:345-351.
2. Helgason CM, Bolin K, Hoff JA, Tortorice K, Winkler SR, Brace LD: Increase dosage requirement and aspirin resistance in patients with previous stroke. Stroke 1994;14:2331-2337.
3. Grotemeyer KH, Scharafinski HW, Husstedt IW: Two-year follow-up of aspirin responders and aspirin non-responders: a pilot study including 180 post-stroke patients. Thromb Res 1993;71:397-403.
4. Wang TH, Bhatt DL, Topol EJ: Aspirin and clopidogrel resistance: an emerging entity. Eur Heart J 2006;27:647-654.
5. Nutescu E, Helgason CM: Combination aspirin-clopidogrel therapy (abstract). Stroke 2000;31:298.
6. Eikelboom JW, Hankey GJ, Thom J, Claxton A, Yi Q, Gilmore G, Staton J, Barden A, Norman PE: Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 2005;3:2649-2655.
7. Santos TM, Valles J, Aznar J, Lago A, Sanchez E, Cosin J, Moscardo A, Pinon M, Broekman MJ, Marcus AJ: Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease. J Lab Clin Med 2006;147:220-227.
8. Cattaneo M: Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor. Arterioscler Thromb Vasc Biol 2004;24:1980-1987.
9. Borna C, Lazarowski E, Van Heusden C, Ohlin H, Erlinge D: Resistance to aspirin is increased by ST elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J 2005;3:1-10.
10. Bhatt DL, Fox KAA, Hacke W: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717.
11. Santos MT, Valles J, Aznar J, Marcus AJ, Broekman MJ, Safier LB: Prothrombotic effects of erythrocytes on platelet reactivity. Circulation 1997;95:63-68.
12. Santos VJ, Aznar J, Valert M, Barbera G, Carmena R: Modulatory effect of erythrocytes on the platelet reactivity to collagen in IDDM patients. Diabetes 1997;46:1047-1053.
13. Valles J, Santos MT, Aznar AJ, Martinez M, Mosardo A, Pinon M, Broekman MJ, Marcus AJ: Platelet-erythrocyte interactions enhance alpha IIb beta 3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo. Blood 2002;99:3978-3984.
14. Marcus AJ, Broekman MJ, Drosopoulos JHF, Pinsky DJ, Islam N, Maliszewski CR: Inhibition of platelet recruitment by endothelial cell CD 39/ecto-ADPase: significance for occlusive vascular disease. Italian Heart J 2001;2:824-830.
15. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J: Enhancment of platelet reactivity and modulation of eicosanoid production by intact erythrocytes: a new approach to platelet activation and recruitment. J Clin Invest 1991;87:571-580.
16. Santos MT, Valles J, Aznar J: Cell-cell interactions in thrombosis: modulation of platelet function and possibilities of pharmacologic control. Turk J Haematol 2002;19:103-111.
17. Valles J, Santos MT, Aznar J, Osa A, Lago A, Cosin J, Sanchez E, Broekman MJ, Ma AJ: Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an anti-thrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to pro-thrombotic effects of erythrocytes on platelet reactivity. Circulation 1998;97:350-355.
18. Helgason CM, Hoff JA, Kondos GT, Brace LD: Platelet aggregation studies in patients with atrial fibrillation taking aspirin or warfarin. Stroke 1993;24:1458-1466.
19. Buscema M, Terzi S: PST: An evolutionary approach to the problem of multi-dimensional scaling. WSEAS Trans Inf Sci Appl 2006;9:1704-1710.
20. Buscema M: Genetic doping algorithm (GenD): theory and applications. Expert Syst 2004;21:63-69.
21. Kruskal JB: On the shortest spanning subtree and the traveling salesman problem. Proc Am Math Soc 1956;7:48-50.
22. Diener HC, Bogousslavsky J, et al: Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 2004;364:331-337.
23. Hotelling H: Analysis of a complex of statistical variables into principal components. J Educ Psychol 1933;24:417-441.
24. Comon P: Independent component analysis - a new concept? Signal Processing 1994;36:287-314.
25. Frelinger AL, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD: Residual arachidonic acid induced platelet activiation via an adenosin diphosphate dependent but cyclooxygenase 1 and cyclooxygenase 2 independent pathway. Circulation 2006;113:2888-2896.
26. Tantry US, Bliden KP, Gurbel PA: Overestimation of platelet aspirin resistance detected by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 2005;46:1705-1709.
27. Golanski J, Pluta J, Baraniak J, Watala C: Limited usefulness of the PFA-100 TM for the monitoring of ADP receptor antagonists - in vitro experience. Clin Chem Lab Med 2004;42:25-29.